Select Medical (NYSE:SEM) Sees Unusually-High Trading Volume – What’s Next?

Shares of Select Medical Holdings Corporation (NYSE:SEM) saw strong trading volume on Wednesday . 2,925,040 shares were traded during mid-day trading, an increase of 176% from the previous session’s volume of 1,060,913 shares.The stock last traded at $16.25 and had previously closed at $16.26.

Trending Headlines about Select Medical

Here are the key news stories impacting Select Medical this week:

• Positive Sentiment: Definitive buyout agreed — consortium led by Executive Chairman Robert A. Ortenzio, Martin F. Jackson and WCAS will acquire Select Medical for $16.50 in cash per share (implied enterprise value ~$3.9B); the special committee approved the deal, insiders plan some rollover and the merger is not subject to a financing condition, with an expected close in mid‑2026. Select Medical announced definitive merger agreement
• Positive Sentiment: Market reaction — shares have rallied as traders and arbitrageurs moved toward the $16.50 deal price, lifting volume and pushing the stock materially higher since the announcement. SEM’s $16.50 take-private moment
• Neutral Sentiment: Analyst positioning — several broker targets sit at or near the $16.50 offer (e.g., recent $16.50 targets), implying limited upside beyond the deal price and leaving the stock effectively tied to completion risk. QuiverQuant summary of deal and analyst context
• Neutral Sentiment: Merger-arbitrage considerations — some analysts note the $16.50 offer could be “undervalued” relative to longer-term forecasts, creating debate over whether remaining upside exists versus deal-close certainty and timing. Zacks take on timing vs valuation
• Negative Sentiment: Multiple shareholder investigations and potential litigation — several law firms (Kahn Swick & Foti, Halper Sadeh, Monteverde & Associates, Brodsky & Smith, Ademi LLP, etc.) have launched probes into whether the $16.50 price and the sale process were fair, increasing the risk of lawsuits, injunctions or delays to closing. KSF investor alert on proposed sale
• Negative Sentiment: Insider-led buyout and conflict concerns — the deal is led by company executives/directors and some insiders will roll equity, which is cited in the investigator filings and could provoke shareholder challenges or regulatory scrutiny that affect timing and certainty. Acquirer and deal structure details

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Zacks Research cut shares of Select Medical from a “hold” rating to a “strong sell” rating in a research report on Thursday, February 26th. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Benchmark reaffirmed a “hold” rating on shares of Select Medical in a research report on Wednesday. Wall Street Zen raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $16.50 price objective (down from $19.00) on shares of Select Medical in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Select Medical presently has a consensus rating of “Hold” and a consensus target price of $15.63.

Select Medical Price Performance

The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $2.02 billion, a PE ratio of 14.15, a price-to-earnings-growth ratio of 0.85 and a beta of 1.22. The business has a 50-day moving average of $15.31 and a 200 day moving average of $14.23.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, February 19th. The health services provider reported $0.16 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.07). Select Medical had a net margin of 2.68% and a return on equity of 7.26%. The firm had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter in the prior year, the company earned $0.18 EPS. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, research analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 12th. Stockholders of record on Monday, March 2nd will be issued a $0.0625 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. Select Medical’s dividend payout ratio is currently 21.74%.

Select Medical announced that its Board of Directors has initiated a stock repurchase plan on Thursday, February 19th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the health services provider to purchase up to 49.5% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board of directors believes its stock is undervalued.

Institutional Trading of Select Medical

Several hedge funds have recently added to or reduced their stakes in SEM. Quarry LP bought a new position in shares of Select Medical during the 4th quarter valued at approximately $26,000. Caitong International Asset Management Co. Ltd bought a new position in Select Medical during the fourth quarter valued at $28,000. Quantbot Technologies LP purchased a new stake in Select Medical in the third quarter worth $27,000. MAI Capital Management raised its stake in shares of Select Medical by 48,000.0% in the second quarter. MAI Capital Management now owns 2,405 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,400 shares during the period. Finally, Hantz Financial Services Inc. lifted its stake in shares of Select Medical by 214.7% during the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock valued at $38,000 after buying an additional 1,739 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.